Asset profile

bosakitug · Aclaris (ACRS)

Indication
moderate-to-severe atopic dermatitis
Also known as
ATI-045
CompanyACRSAclaris

Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company. It focuses on developing novel drug candidates for immuno-inflammatory diseases using its proprietary KINect drug discovery platform. The company's pipeline consists of the following key p…

On the calendar

Nothing scheduled in this window.

Timeline

Newest first.

Registered trials

Registry IDPhaseStatusPrimary completionEnrollmentSites
NCT07011706Phase 2Active, not recruitingSep 21, 202611053 of 60 sites in the United States

More from Aclaris

Other drugs and candidates from the same company tracked in this sector.

bosakitug · Aclaris (ACRS) — FDA Timeline & Readiness Checklist | SimianX AI